Skip to main content
Clinical Trials/NCT00624221
NCT00624221
Completed
Not Applicable

A Prospective, Randomized, Single Center Study Evaluating Use of Surgeon- and Eye Bank-prepared Donor Tissue for Descemet's Stripping and Endothelial Keratoplasty, a Type of Cornea Transplant

Cornea Research Foundation of America1 site in 1 country40 target enrollmentJanuary 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fuchs Endothelial Dystrophy
Sponsor
Cornea Research Foundation of America
Enrollment
40
Locations
1
Primary Endpoint
Endothelial Cell Loss
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Descemet's stripping with endothelial keratoplasty (DSEK) is a cornea-sparing transplant technique that replaces only the diseased endothelial cell layer of the patient's cornea. The DSEK technique requires lamellar dissection of the donor tissue prior to implantation in the patient's eye. The surgeon usually dissects the donor cornea with a microkeratome at the time of surgery. Recently some eye banks have begun to pre-cut the donor graft as an added service. The purpose of this study was to compare outcomes with eye bank pre-cut and surgeon-dissected donor grafts for DSEK.

Registry
clinicaltrials.gov
Start Date
January 2006
End Date
November 2007
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • candidate for Descemet's stripping with endothelial keratoplasty
  • at least 21 years old
  • willing and able to return for scheduled follow-up visits
  • reads and signs Informed Consent document

Exclusion Criteria

  • visual acuity of less than 20/400 in fellow eye
  • known sensitivity to planned study concomitant medications

Outcomes

Primary Outcomes

Endothelial Cell Loss

Time Frame: 6 months after grafting

Endothelial cell density was measured by specular or confocal microscopy. Percent cell loss was calculated by subtracting the graft endothelial cell density measured at 6 months from the baseline donor endothelial cell density and dividing by the baseline donor endothelial cell density then multiplying by 100.

Secondary Outcomes

  • Best Corrected Vision(6 months and 1 year after grafting)
  • Graft Dislocation(1 day to 1 month after grafting)

Study Sites (1)

Loading locations...

Similar Trials